Results 41 to 50 of about 862 (170)
Novi VP2/VP3 rekombinantni senekavirus A izoliran u sjevernoj Kini [PDF]
, 2023 Senecavirus A (SVA), previously called the Seneca Valley virus, is the only member of the genus Senecavirus within the family Picornaviridae. This virus was discovered as a serendipitous finding in 2002 and named Seneca Valley virus 001 (SVV-001). SVA is
Han, Hong +12 more
core +2 more sources
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
Frontiers in Molecular Biosciences, 2022 Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators.
Virginia Corbett +3 more
doaj +1 more source
Deubiquitylating Enzymes in Cancer and Immunity
Advanced Science, Volume 10, Issue 36, December 27, 2023., 2023 This review presents the fundamental understanding of deubiquitinating enzymes (DUBs) and then outlines the mechanisms and multi‐role of DUBs in determining the occurrence and development of tumor and immune disorders. DUBs in the crosstalk between cancer and immune response is then presented.
Jiang Ren +8 more
wiley +1 more source
Virology Journal, 2022 Background Seneca Valley virus (SVV) is a picornavirus that causes vesicular disease in swine. Clinical characteristics of the disease are similar to common viral diseases such as foot-and-mouth disease virus, porcine vesicular disease virus, and ...
Wei Wen +5 more
doaj +1 more source
Genome-Wide Analysis of Long Noncoding RNA Profiles in Seneca Valley Virus–Infected PK15 Cells
Frontiers in Veterinary Science, 2022 Long noncoding RNAs (lncRNAs) have been demonstrated to play key roles in various biological processes. However, the contributions of lncRNAs to Seneca Valley virus (SVV) infection and host defense remain largely unknown.
Jianguo Dong +4 more
doaj +1 more source
Oncolytic viral therapy as promising immunotherapy against glioma
MedComm – Future Medicine, Volume 2, Issue 4, December 2023., 2023 Multiple preclinical experiments and clinical trials have shown that oncolytic viruses (OVs) exhibit good antitumor activity in treating gliomas. This article summarizes the crucial clinical progress of various OVs in the treatment of glioma, the challenges faced by OVs in the treatment of glioma, and looks forward to the future development prospects ...
Die Hu +7 more
wiley +1 more source
Intercellular transmission of Seneca Valley virus mediated by exosomes
Veterinary Research, 2020 Seneca Valley virus (SVV) is a non-encapsulated single-stranded positive-strand RNA virus whose transmission routes have not yet been fully elucidated.
Guowei Xu +10 more
doaj +1 more source
Vaccines, 2022 Seneca Valley virus (SVV), also known as Senecavirus A (SVA), is a non-enveloped and single-strand positive-sense RNA virus, which belongs to the genus of Senecavirus within the family Picornaviridae. Porcine idiopathic vesicular disease (PIVD) caused by
Wenqiang Liu +7 more
doaj +1 more source
CA: A Cancer Journal for Clinicians, Volume 73, Issue 6, Page 620-652, November/December 2023., 2023 Abstract Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority of SCLCs exhibit neuroendocrine features, an important subset of tumors lacks these properties.
Zsolt Megyesfalvi +16 more
wiley +1 more source
Frontiers in Veterinary Science, 2021 Pigs are the main host of Seneca Valley virus (SVV), previously known as Senecavirus A (SVA). Pigs affected by SVV have vesicles in the nose, hooves, and limp and may cause death in some severe cases.
Xia Zhou +18 more
doaj +1 more source